Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma
- PMID: 19004985
- DOI: 10.1530/EJE-08-0548
Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma
Abstract
Objective: Environmental and genetic factors influence thyrotoxicosis, but how population migration affects the disease panorama is not known. In an urban area in southern Sweden, during the years 1990 until 2003, the population increased from 232 000 to 267 000. In parallel, the proportion of inhabitants born outside Sweden increased. The aim was to investigate whether the incidence of Graves' thyrotoxicosis (GD), toxic multinodular goiter (TMNG), and solitary toxic adenoma (STA) has changed in Malmö since 1990 and to study the influence of geographic origin.
Design and method: An open label prospective registration of thyrotoxicosis, gender, age, smoking habits, and ethnic background during 2003-2005 in an urban area in southern Sweden (Malmö) was undertaken.
Results: The total incidence of thyrotoxicosis has changed from 43 to 41.6 cases/100,000/year from the years 1988-1990 to 2003-2005 (p-value 0.72). GD increased from 22 to 29.6 (p-value 0.0051), TMNG decreased from 16 to 9.9 (p-value 0.0011) and STA from 4.8 to 2.1 (p-value 0.0054)/100,000/year. The total incidence of GD was higher in inhabitants born outside Sweden up to the age of 69 years and age-specific incidence showed a peak in women aged 50-59 years old in both groups. The greatest difference between immigrants and Swedes up to the age of 69 years was observed in women aged 20-29 years old.
Conclusion: The incidence of GD has increased and of TMNG has decreased in Malmö since 1990. Geographic origin seems to affect the incidence of GD. Whether the observed peak in age-related incidence in women 50-59 years is explained by menopausal changes has to be further investigated.
Similar articles
-
Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970-74.J Intern Med. 1990 Feb;227(2):137-41. doi: 10.1111/j.1365-2796.1990.tb00132.x. J Intern Med. 1990. PMID: 2299305
-
Increased incidence of thyrotoxicosis in Malmö during the years 1988-1990 as compared to the years 1970-1974.J Intern Med. 1996 Jan;239(1):57-62. doi: 10.1046/j.1365-2796.1996.415757000.x. J Intern Med. 1996. PMID: 8551201
-
Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.Gerontology. 2003 Sep-Oct;49(5):316-23. doi: 10.1159/000071713. Gerontology. 2003. PMID: 12920352
-
Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter.Endocrinol Metab Clin North Am. 1998 Mar;27(1):151-68. doi: 10.1016/s0889-8529(05)70304-2. Endocrinol Metab Clin North Am. 1998. PMID: 9534034 Review.
-
[Incidence of the most frequently occurring diseases causing hyperthyroidism syndrome].Orv Hetil. 1989 Sep 10;130(37):1967-71. Orv Hetil. 1989. PMID: 2674848 Review. Hungarian.
Cited by
-
Selective IgA deficiency in autoimmune diseases.Mol Med. 2011;17(11-12):1383-96. doi: 10.2119/molmed.2011.00195. Epub 2011 Aug 4. Mol Med. 2011. PMID: 21826374 Free PMC article. Review.
-
Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden.Br J Cancer. 2010 Apr 27;102(9):1397-9. doi: 10.1038/sj.bjc.6605624. Epub 2010 Mar 30. Br J Cancer. 2010. PMID: 20354521 Free PMC article.
-
Thyroid peroxidase antibodies and their role in predicting outcomes in Graves' disease treatment.Front Endocrinol (Lausanne). 2025 Apr 4;16:1517283. doi: 10.3389/fendo.2025.1517283. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40255503 Free PMC article.
-
The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease.Eur Thyroid J. 2019 Apr;8(2):64-69. doi: 10.1159/000495504. Epub 2019 Jan 3. Eur Thyroid J. 2019. PMID: 31192144 Free PMC article.
-
Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.Trials. 2013 Apr 30;14:119. doi: 10.1186/1745-6215-14-119. Trials. 2013. PMID: 23782950 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical